Latest Stories

B
Screener

3 of Wall Street’s Favorite Stocks with Open Questions

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

Dec 03, 2025
S
Screener

3 Large-Cap Stocks That Fall Short

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.

Dec 03, 2025
E
Screener

3 Small-Cap Stocks with Warning Signs

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.

Dec 03, 2025
M
Screener

2 High-Flying Stocks to Keep an Eye On and 1 Facing Challenges

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly susceptible to drawdowns when market sentiment shifts.

Dec 03, 2025
A
Three Reasons

3 Reasons to Avoid ANGI and 1 Stock to Buy Instead

Angi has gotten torched over the last six months - since June 2025, its stock price has dropped 28.7% to $12.01 per share. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.

Dec 03, 2025
F
Screener

3 Consumer Stocks with Warning Signs

Consumer discretionary businesses are levered to the highs and lows of economic cycles. Thankfully for the industry, all signs are pointing up as discretionary stocks have gained 19.1% over the past six months, beating the S&P 500’s 14.1% return.

Dec 03, 2025
M
Screener

1 Healthcare Stock with Promising Prospects and 2 We Question

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have realized strong financial performance, and over the past six months, the industry’s 15.5% return has closely followed the S&P 500.

Dec 03, 2025
B
Screener

2 Volatile Stocks with Exciting Potential and 1 We Question

Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced investors.

Dec 03, 2025
J
Screener

1 Small-Cap Stock with Competitive Advantages and 2 Facing Headwinds

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.

Dec 03, 2025
A
Screener

3 Healthcare Stocks We’re Skeptical Of

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately - over the past six months, healthcare stocks have gained 15.5%, nearly mirrorring the S&P 500.

Dec 03, 2025